Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), University of Coimbra, Coimbra, Portugal.
Institute for Nuclear Sciences Applied to Health (ICNAS), University of Coimbra, Coimbra, Portugal.
BMJ Open. 2024 Apr 2;14(4):e080702. doi: 10.1136/bmjopen-2023-080702.
Bariatric surgery (BS) is the treatment of choice for refractory obesity. Although weight loss (WL) reduces the prevalence of obesity-related comorbidities, not all patients maintain it. It has been suggested that central mechanisms involving dopamine receptors may play a role in successful WL. This protocol describes an observational cross-sectional study to test if the binding of central dopamine receptors is similar in individuals who responded successfully to BS and age- and gender-matched normal-weight healthy individuals (controls). As secondary goals, the protocol will investigate if this binding correlates with key parameters such as age, hormonal status, anthropometric metrics and neurobehavioural scores. Finally, as exploratory goals, we will include a cohort of individuals with obesity before and after BS to explore whether obesity and type of BS (sleeve gastrectomy and Roux-en-Y gastric bypass) yield distinct binding values and track central dopaminergic changes resulting from BS.
To address the major research question of this observational study, positron emission tomography (PET) with [C]raclopride will be used to map brain dopamine type 2 and 3 receptors (D2/3R) non-displaceable binding potential (BP) of individuals who have successfully responded to BS. Mean regional D2/3R BP values will be compared with control individuals by two one-sided test approaches. The sample size (23 per group) was estimated to demonstrate the equivalence between two independent group means. In addition, these binding values will be correlated with key parameters to address secondary goals. Finally, for exploratory analysis, these values will be compared within the same individuals (before and after BS) and between individuals with obesity and controls and types of BS.
The project and informed consent received ethical approval from the Faculty of Medicine and the Coimbra University Hospital ethics committees. Results will be disseminated in international peer-reviewed journals and conferences.
减重手术(BS)是治疗难治性肥胖的首选方法。虽然体重减轻(WL)降低了肥胖相关合并症的患病率,但并非所有患者都能维持体重减轻。有人提出,涉及多巴胺受体的中枢机制可能在成功的 WL 中发挥作用。本方案描述了一项观察性横断面研究,以测试成功接受 BS 治疗的个体与年龄和性别匹配的正常体重健康个体(对照组)的中枢多巴胺受体结合是否相似。作为次要目标,该方案将研究这种结合是否与年龄、激素状态、人体测量指标和神经行为评分等关键参数相关。最后,作为探索性目标,我们将纳入一组肥胖患者在 BS 前后,以探讨肥胖和 BS 类型(胃袖状切除术和 Roux-en-Y 胃旁路术)是否产生不同的结合值,并追踪 BS 引起的中枢多巴胺变化。
为了解决这项观察性研究的主要研究问题,将使用[C]raclopride 正电子发射断层扫描(PET)来绘制成功接受 BS 治疗的个体的大脑多巴胺 2 型和 3 型受体(D2/3R)不可置换结合潜能(BP)。通过两种单边检验方法,将平均区域 D2/3R BP 值与对照组个体进行比较。估计样本量(每组 23 个)以证明两个独立组均值的等效性。此外,这些结合值将与关键参数相关,以解决次要目标。最后,对于探索性分析,将在同一患者(BS 前后)之间以及肥胖患者与对照组和 BS 类型之间比较这些值。
该项目和知情同意书获得了医学院和科英布拉大学医院伦理委员会的伦理批准。研究结果将在国际同行评议期刊和会议上发表。